Bosman Romy, Duraku Liron S, van der Oest Mark J W, Hundepool C A, Rajaratnam Vaikunthan, Power D M, Selles Ruud W, Zuidam J Michiel
Department of Plastic, Reconstructive Surgery and Hand Surgery, Erasmus Medical Centre, Rotterdam, the Netherlands.
Department of Plastic, Reconstructive and Hand Surgery, Amsterdam UMC, Amsterdam, the Netherlands.
Plast Reconstr Surg Glob Open. 2022 May 6;10(5):e4305. doi: 10.1097/GOX.0000000000004305. eCollection 2022 May.
Surgical release of the extensor retinaculum is performed as a treatment for de Quervain's (DQ) disease when conservative treatment fails. In the literature, there is no consensus about the effectiveness of a surgical release in patients with DQ, the complication rate, or which type of incision is superior. Therefore, a systematic review and meta-analysis were conducted.
A systematic search was performed in Embase, Medline Ovid, Web of Science Core Collection, Cochrane, and Google Scholar. Articles regarding surgical treatment of DQ disease that reported outcome and complications were included. We extracted exact values of visual analog scale scores and percentages of patients who experienced pain at follow-up. Complications assessed were (sub) luxation, superficial radial nerve injuries, wound infections, and scar problems.
Twenty-one studies with a total of 939 patients were included. Five percent of these patients (95% CI 1%-18%) did not show complete remission of pain at follow-up. When pooled, the mean reduction in visual analog scale scores was 5.7 (95% CI 5.3-6.1) on a 0-10 scale. No difference in outcome between different types of surgery or incisions was seen. Based on the meta-analysis, the pooled complication rate was 11% (95% CI 5%-22%).
Five percent of patients still have residual pain after surgical release of the first extensor compartment. Surgery type, as well as the type of incision, did not affect outcome or complication. Thus, surgical release of the extensor retinaculum for DQ disease is an effective treatment, regardless of the type of surgery.
当保守治疗失败时,伸肌支持带松解术可用于治疗桡骨茎突狭窄性腱鞘炎(DQ)。在文献中,对于DQ患者手术松解的有效性、并发症发生率或哪种切口类型更优尚无共识。因此,我们进行了一项系统评价和荟萃分析。
在Embase、Medline Ovid、Web of Science核心合集、Cochrane和谷歌学术上进行了系统检索。纳入了报告手术治疗DQ疾病结果和并发症的文章。我们提取了视觉模拟量表评分的精确值以及随访时仍有疼痛的患者百分比。评估的并发症包括(半)脱位、桡神经浅支损伤、伤口感染和瘢痕问题。
共纳入21项研究,总计939例患者。其中5%的患者(95%可信区间1%-18%)在随访时疼痛未完全缓解。汇总后,视觉模拟量表评分的平均降低值在0-10分制上为5.7(95%可信区间5.3-6.1)。不同手术类型或切口之间的结果未见差异。基于荟萃分析,汇总并发症发生率为11%(95%可信区间5%-22%)。
在对第一伸肌间隔进行手术松解后,5%的患者仍有残留疼痛。手术类型以及切口类型均不影响结果或并发症。因此,无论手术类型如何,伸肌支持带松解术治疗DQ疾病都是一种有效的治疗方法。